Regulation of Bone Formation in Renal Osteodystrophy

NCT00560300 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

Secondary Hyperparathyroidism
Renal Osteodystrophy

Interventions

DRUG: 1 alpha D2
DRUG: 1,25 dihydroxy vitamin D3
DRUG: Sevelamer HCl
DRUG: Calcium Carbonate

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)